Ruby Pelingon
Impact in
- Microbiology top 5%
- Antimicrobial Peptides and Activities
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antimicrobial Peptides and Activities 4
-
- Antibiotic Resistance in Bacteria 2
- Co-authors
- Matthew A. Cooper (9 shared papers)Mark S. Butler (8 shared papers)Mark A. T. Blaskovich (6 shared papers)Alysha G. Elliott (3 shared papers)Johnny X. Huang (3 shared papers)Soumya Ramu (2 shared papers)Angela M. Kavanagh (2 shared papers)Wanida Phetsang (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (2 papers)Nature Communications (2 papers)Science Translational Medicine (1 paper)ACS Medicinal Chemistry Letters (1 paper)Analytical Biochemistry (1 paper)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Ruby Pelingon
13 papers receiving 601 citations
Peers
Comparison fields: 5 of 65
- Microbiology 124
- Molecular Medicine 100
- Organic Chemistry 146
- Pharmacology 65
- Drug Discovery 1
Countries citing papers authored by Ruby Pelingon
This map shows the geographic impact of Ruby Pelingon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby Pelingon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby Pelingon more than expected).
Fields of papers citing papers by Ruby Pelingon
This network shows the impact of papers produced by Ruby Pelingon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby Pelingon. The network helps show where Ruby Pelingon may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruby Pelingon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 132 | |
| 2 | 2016 | 110 | |
| 3 | 2015 | 95 | |
| 4 | 2017 | 55 | |
| 5 | 2016 | 51 | |
| 6 | 2016 | 46 | |
| 7 | 2016 | 43 | |
| 8 | 2019 | 36 | |
| 9 | 2018 | 24 | |
| 10 | 2022 | 15 | |
| 11 | 2025 | 6 | |
| 12 | 2020 | 4 | |
| 13 | 2025 | 1 |
About Ruby Pelingon
Ruby Pelingon is a scholar working on Microbiology, Molecular Medicine, Infectious Diseases, Molecular Biology and Parasitology, having authored 13 papers that have together received 618 indexed citations. Recurring topics across this work include Antimicrobial Peptides and Activities (4 papers), Inflammasome and immune disorders (3 papers), Synthesis and Biological Evaluation (2 papers), Antibiotic Resistance in Bacteria (2 papers), Streptococcal Infections and Treatments (1 paper), Amoebic Infections and Treatments (1 paper), RNA Interference and Gene Delivery (1 paper) and Parasitic Infections and Diagnostics (1 paper). The work is most often cited by research in Microbiology (124 citations), Molecular Medicine (100 citations), Organic Chemistry (146 citations), Pharmacology (65 citations) and Drug Discovery (1 citation). Ruby Pelingon has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Matthew A. Cooper, Mark S. Butler, Mark A. T. Blaskovich, Alysha G. Elliott, Johnny X. Huang, Soumya Ramu, Angela M. Kavanagh, Wanida Phetsang, Alejandra Gallardo‐Godoy and Craig A. Muldoon. Their work appears in journals such as Journal of Medicinal Chemistry, Nature Communications, Science Translational Medicine, ACS Medicinal Chemistry Letters and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.